Molecular determinants of arterial calcification

Annals of Medicine

Volumn 30, Issue 6, 1998, Pages 538-541

  Schinke, Thorsten ^a   McKee, Marc D ^b,c   Kiviranta, Riku ^d   Karsenty, Gerard ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b MCGILL UNIVERSITY   (Canada)

^c MRC Group in Peridontal Physiology   (Canada)

^d UNIVERSITY OF TURKU   (Finland)

Author keywords

Arteries; Calcification; Extracellular matrix; Matrix Gla protein; Osteoprotegerin

Indexed keywords

OSTEOCALCIN;

AORTA MEDIA; ARTERY CALCIFICATION; ARTICLE; ATHEROSCLEROSIS; EXTRACELLULAR MATRIX; GENETIC REGULATION; HUMAN; PRIORITY JOURNAL;

EID: 0032408853     PISSN: 07853890     EISSN: None     Source Type: Journal    
DOI: 10.3109/07853899709002601     Document Type: Article

References (38)

1. Tanimura A, McGregor DH, Anderson HC. Matrix vesicles in atherosclerotic calcification. Proc Soc Exp Biol Med 1983; 172: 173-7.
2. Watson KE, Bostrom K, Ravindranath R, Lam T, Norton B, Demer LL. TGF-beta 1 and 25-hydroxycholesterol stimulate osteoblast-like vascular cells to calcify. J Clin Invest 1994; 93: 2106-13.
3. Giachelli CM, Bae N, Almeida M, Denhardt DT, Alpers CE, Schwartz SM. Osteopontin is elevated during neointima formation in rat arteries and is a novel component of human atherosclerotic plaques. J Clin Invest 1993; 92: 1686-96.
4. Hunter GK, Kyle CL, Goldberg HA. Modulation of crystal formation by bone phosphoproteins: structural specificity of the osteopontin-mediated inhibition of hydroxyapatite formation. Biochem J 1994; 300: 723-8.
5. Kajander EO, Ciftcioglu N. Nanobacteria: an alternative mechanism for pathogenic intra-and extracellular calcification and stone formation. Proc Natl Acad Sci U S A 1998; 95: 8274-9.
6. Kim KM, Huang SN. Ultrastructural study of calcification of human aortic valve. Lab Invest 1971; 25: 357-66.
7. Kim KM. Calcification of matrix vesicles in human aortic valve and aortic media. Fed Proc 1976; 35: 156-62.
8. Morgan AJ. Mineralized deposits in the thoracic aorta of aged rats: ultrastructural and electron probe x-ray microanalysis study. Exp Gerontol 1980; 15: 563-73.
9. Ross R. The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature 1993; 362: 801-9.
10. Breslow JL. Mouse models of atherosclerosis. Science 1996; 272: 685-8.
11. Stary HC. The sequence of cell and matrix changes in atherosclerotic lesions of coronary arteries in the first forty years of life. Eur Heart J 1990; 11 Suppl E: 3-19.
12. Stary HC, Chandler AB, Dinsmore RE, et al. A definition of advanced types of atherosclerotic lesions and a histological classification of atherosclerosis. A report from the Committee on Vascular Lesions of the Council on Arteriosclerosis, American Heart Association. Arterioscler Thromb Vasc Biol 1995; 15: 1512-31.
13. Detrano RC, Wong ND, Tang W, et al. Prognostic significance of cardiac cinefluoroscopy for coronary calcific deposits in asymptomatic high risk subjects. J Am Coll Cardiol 1994; 24: 354-8.
14. Fitzgerald PJ, Ports TA, Yock PG. Contribution of localized calcium deposits to dissection after angioplasty. An observational study using intravascular ultrasound. Circulation 1992; 86: 64-70.
15. Zhang SH, Reddick RL, Piedrahita JA, Maeda N. Spontaneous hypercholesterolemia and arterial lesions in mice lacking apolipoprotein E. Science 1992; 258: 468-71.
16. Plump AS, Smith JD, Hayek T, et al. Severe hypercholesterolemia and atherosclerosis in apolipoprotein E-deficient mice created by homologous recombination in ES cells. Cell 1992; 71: 343-53.
17. Reddick RL, Zhang SH, Maeda N. Atherosclerosis in mice lacking apo E. Evaluation of lesional development and progression. Arterioscler Thromb 1994; 14: 141-7.
18. van Vlijmen BJ, van den Maagdenberg AM, Gijbels MJ, et al. Diet-induced hyperlipoproteinemia and atherosclerosis in apolipoprotein E3-Leiden transgenic mice. J Clin Invest 1994; 93: 1403-10.
19. Fazio S, Sanan DA, Lee YL, Ji ZS, Mahley RW, Rall SC Jr. Susceptibility to diet-induced atherosclerosis in transgenic mice expressing a dysfunctional human apolipoprotein E (Arg 112,Cys142). Arterioscler Thromb 1994; 14: 1873-9.
20. Ishibashi S, Goldstein JL, Brown MS, Herz J, Burns DK. Massive xanthomatosis and atherosclerosis in cholesterol-fed low density lipoprotein receptor-negative mice. J Clin Invest 1994; 93: 1885-93.
21. Qiao JH, Xie PZ, Fishbein MC, et al. Pathology of atheromatous lesions in inbred and genetically engineered mice. Genetic determination of arterial calcification. Arterioscler Thromb 1994; 14: 1480-97.
22. Maayan C, Peleg O, Eyal F, Mogle P, Rosenmann E, Bar Ziv J. Idiopathic infantile arterial calcification: a case report and review of the literature. Eur J Pediatr 1984; 142: 211-5.
23. Singleton EB, Merten DF. An unusual syndrome of widened medullary cavities of the metacarpals and phalanges, aortic calcification and abnormal dentition. Pediatr Radiol 1973; 1: 2-7.
24. Gay BB Jr, Kuhn JP. A syndrome of widened medullary cavities of bone, aortic calcification, abnormal dentition, and muscular weakness (the Singleton-Merten syndrome). Radiology 1976; 118: 389-95.
25. Uitto J, Boyd CD, Lebwohl MG, Moshell AN, Rosenbloom J, Terry S. International Centennial Meeting on Pseudoxanthoma Elasticum: progress in PXE research. J Invest Dermatol 1998; 110: 840-2.
26. Pope FM. Autosomal dominant pseudoxanthoma elasticum. J Med Genet 1974; 11: 152-7.
27. Pasquali-Ronchetti I, Volpin D, Baccarani-Contri M, Castellani I, Peserico A. Pseudoxanthoma elasticum. Biochemical and ultrastructural studies. Dermatologica 1981; 163: 307-25.
28. Suttie JW. Mechanism of action of vitamin K: synthesis of gamma-carboxyglutamic acid. CRC Crit Rev Biochem 1980; 8: 191-223.
29. Furie B, Furie BC. The molecular basis of blood coagulation. Cell 1988; 53: 505-18.
30. Hauschka PV, Lian JB, Cole DE, Gundberg CM. Osteocalcin and matrix Gla protein: vitamin K-dependent proteins in bone. Physiol Rev 1989; 69: 990-1047.
31. Luo G, Ducy P, McKee MD, et al. Spontaneous calcification of arteries and cartilage in mice lacking matrix GLA protein. Nature 1997; 386: 78-81.
32. Franco B, Meroni G, Parenti G, et al. A cluster of sulfatase genes on Xp22.3: mutations in chondrodysplasia punctata (CDPX) and implications for warfarin embryopathy. Cell 1995; 81: 15-25.
33. Teebi AS, Lambert DM, Kaye GM, Al-Fifi S, Tewfik TL, Azouz EM. Keutel syndrome: further characterization and review. Am J Med Genet 1998; 78: 182-7.
34. Vermeer C. Gamma-carboxyglutamate-containing proteins and the vitamin K-dependent carboxylase. Biochem J 1990; 266: 625-36.
35. Simonet WS, Lacey DL, Dunstan CR, et al. Osteoprotegerin: a novel secreted protein involved in the regulation of bone density. Cell 1997; 89: 309-19.
36. Bucay N, Sarosi I, Dunstan CR, et al. Osteoprotegerin-deficient mice develop early onset osteoporosis and arterial calcification. Genes Dev 1998; 12: 1260-8.
37. Terpening CM, Haussler CA, Jurutka PW, Galligan MA, Komm BS, Haussler MR. The vitamin D-responsive element in the rat bone Gla protein gene is an imperfect direct repeat that cooperates with other cis-elements in 1,25-dihydroxy-vitamin D3-mediated transcriptional activation. Mol Endocrinol 1991; 5: 373-85.
38. Watson KE, Abrolat ML, Malone LL, et al. Active serum vitamin D levels are inversely correlated with coronary calcification. Circulation 1997; 96: 1755-60.